Bayer CropScience (BOM:506285) Payments of Debt: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506285 Bayer CropScience Ltd BOM:506285
80 GF Score
Price ₹4,068.85
GF Value ₹5,810.81
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Bayer CropScience Payments of Debt?

Bayer CropScience BOM:506285 +0.01% 80 Payments of Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:506285 with a GF Score™ of 80/100 and a GF Value™ of ₹5,810.81 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Bayer CropScience's Payments of Debt for the three months ended in Jun. 2026 was ₹0 Mil.

Bayer CropScience's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil.

Bayer CropScience Payments of Debt Related Terms

Bayer CropScience Payments of Debt Historical Data

* Premium members only.

The historical data trend for Bayer CropScience's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer CropScience Payments of Debt Chart

Bayer CropScience Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bayer CropScience Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:506285
80GF Score
Bayer CropScience Ltd BOM:506285
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer CropScience Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of ₹0 Mil mean?
Bayer CropScience (BOM:506285) has a Payments of Debt of ₹0 Mil as of Jun. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Bayer CropScience and its competitors.
Is Bayer CropScience's Payments of Debt too high?
Bayer CropScience's current Payments of Debt is ₹0 Mil. Overall, Bayer CropScience has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bayer CropScience's Payments of Debt compare to CTVA and CF?
Bayer CropScience's Payments of Debt of ₹0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for an Agriculture company?
A good Payments of Debt depends on the Agriculture industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Bayer CropScience and its competitors. Bayer CropScience's current Payments of Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer CropScience stock overvalued right now?
Based on GuruFocus' analysis, Bayer CropScience (BOM:506285) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹5,810.81, compared to a current price of ₹4,068.85 — trading 30% below its estimated fair value. The current Payments of Debt is ₹0 Mil. Bayer CropScience's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Bayer CropScience (BOM:506285), the current Payments of Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer CropScience (BOM:506285) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer CropScience stock appears to be undervalued. The current stock price of ₹4,068.85 is trading 30% below its estimated GF Value™ of ₹5,810.81. GuruFocus considers Bayer CropScience to be Significantly Undervalued.

Key valuation signals for BOM:506285:

  • Payments of Debt: ₹0 Mil
  • GF Value™: ₹5,810.81 vs. price of ₹4,068.85 (30% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the BOM:506285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer CropScience Business Description

Other Exchanges BAYERCROP:India
Address Bayer House, Central Avenue, Bayer House, Hiranandani Estate, Thane (West), Thane, MH, IND, 400607
Bayer CropScience Ltd manufactures, distributes, and sells crop protection and hybrid seed products to the agriculture industry. The firm sells fungicides, weedicides, hybrid seeds, consumer in-home pest-control products, and other agrochemical products. Its geographical segments are India, Germany, Bangladesh, and others, of which the vast majority of its revenue comes from India. The company is a subsidiary of Bayer AG, with the majority of common shares owned by its parent company and other Bayer AG subsidiaries.
80GF Score

Get the complete analysis for BOM:506285

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,068.85
Price
₹5,810.81
GF Value